We are live on ! Find out more
ALBO

Albireo Pharma Inc
ALBO

Delisted

ALBO was delisted on the 2nd of March, 2023.

Back to rankings

108 hedge funds and large institutions have $533M invested in Albireo Pharma Inc in 2020 Q3 according to their latest regulatory filings, with 35 funds opening new positions, 37 increasing their positions, 26 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

289% more first-time investments, than exits

New positions opened: 35 | Existing positions closed: 9

96% more capital invested

Capital invested by funds: $272M → $533M (+$261M)

42% more repeat investments, than reductions

Existing positions increased: 37 | Existing positions reduced: 26

32% more funds holding

Funds holding: 82 → 108 (+26)

86% less call options, than puts

Call options by funds: $7.05M | Put options by funds: $51.1M

Holders
108
Holders Change
+26
Holders Change %
+31.71%
% of All Funds
2.18%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.04%
New
35
Increased
37
Reduced
26
Closed
9
Calls
$7.05M
Puts
$51.1M
Net Calls
-$44.1M
Net Calls Change
-$47.6M

Top Buyers

Rank Fund Capital Flow
1
CAM
Cormorant Asset Management
Massachusetts
+$20.4M
2
Marshall Wace
Marshall Wace
United Kingdom
+$17.7M
3
CAC
Cowen and Company
New York
+$17.5M
4
Federated Hermes
Federated Hermes
Pennsylvania
+$14.6M
5
SCM
Sio Capital Management
New York
+$13.9M

Top Sellers

Rank Fund Capital Flow
1
Point72 Asset Management
Point72 Asset Management
Connecticut
-$4.64M
2
ACH
ArrowMark Colorado Holdings
Colorado
-$4.61M
3
PM
Prosight Management
Texas
-$2.22M
4
SCM
Suvretta Capital Management
New York
-$2.14M
5
EP
Eversept Partners
New York
-$2.07M
Name Holding Trade Value Shares
Change 		Change in
Stake
Millennium Management
101
Millennium Management
New York
$9.12K +$7.96M +273,266 New
QT
102
Quantbot Technologies
New York
$6K +$5.83K +200 New
GT
103
Glenmede Trust
Pennsylvania
$3K +$2.21K +76 +304%
TFO
104
Tarbox Family Office
California
$2K – – –
PFGIA
105
Patriot Financial Group Insurance Agency
Massachusetts
$1K – – –
S
106
SignatureFD
Georgia
$1K – – –
Point72 Asset Management
107
Point72 Asset Management
Connecticut
– -$4.64M -175,000 Closed
SCM
108
Suvretta Capital Management
New York
– -$2.14M -80,900 Closed
EP
109
Eversept Partners
New York
– -$2.07M -78,029 Closed
Prudential Financial
110
Prudential Financial
New Jersey
– -$727K -27,446 Closed
Acadian Asset Management
111
Acadian Asset Management
Massachusetts
– -$313K -11,847 Closed
VF
112
Virtu Financial
New York
– -$219K -8,256 Closed
SG Americas Securities
113
SG Americas Securities
New York
– -$192K -7,233 Closed
LC
114
Lindbrook Capital
California
– -$3K -112 Closed
SWM
115
Sugarloaf Wealth Management
Georgia
– -$29 -1 -9%
1 2 3 4
5

ALBO Hedge Fund Activity: Q3 2020 in Review

108 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Albireo Pharma Inc (ALBO) for Q3 2020, worth a combined $533M — up 96% from $272M a quarter earlier.

Buyers outnumbered sellers: 35 funds opened new ALBO positions and 9 closed out — a net gain of 26 holders — while 37 added to existing stakes and 26 trimmed.

The largest buyer was Cormorant Asset Management, opening a new position worth an estimated $20.4M. The largest seller was Point72 Asset Management, exiting entirely with an estimated $4.64M sold.

  • 108 institutional investors held Albireo Pharma Inc (ALBO) as of Q3 2020, up from 82 in Q2 2020.
  • Funds reported $533M of Albireo Pharma Inc stock for Q3 2020, up 96% quarter-over-quarter.
  • 35 funds opened new Albireo Pharma Inc positions in Q3 2020 and 9 closed out, a net change of +26 holders.
  • The largest Albireo Pharma Inc buyer in Q3 2020 was Cormorant Asset Management, an estimated $20.4M added.
  • The largest Albireo Pharma Inc seller in Q3 2020 was Point72 Asset Management, an estimated $4.64M sold.

Based on aggregated 13F filings for Q3 2020.